| UBS (LUX) EQUITY SICAV - EUROPEAN OPPORTUNITY UNCONSTRAINED (EUR) (USD HEDGED) Q-ACC | RVI EUROPA | 20,40% | 33,42% | 50,51% | 157,24% |
| GOLDMAN SACHS JAPAN EQUITY PORTFOLIO I (CLOSE) JPY CAP | RVI JAPÓN | 27,64% | 44,96% | 50,49% | 150,28% |
| DWS INVEST CROCI JAPAN JPY IC | RVI JAPÓN | 21,26% | 31,73% | 50,48% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) HKD | RVI BIOTECNOLOGÍA | 67,94% | 73,65% | 50,48% | 143,64% |
| ISHARES EMERGING MARKETS INDEX FUND (IE) INSTITUTIONAL USD ACC | RVI EMERGENTES | 51,99% | 75,40% | 50,48% | · |
| ABRDN SICAV I-EMERGING MARKETS SDG EQUITY FUND K ACC USD | RVI EMERGENTES | 60,96% | 71,49% | 50,47% | · |
| FIRST EAGLE AMUNDI INTERNATIONAL FUND AE-C | MIXTO FLEXIBLE | 17,05% | 36,86% | 50,44% | 101,01% |
| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) USD | RVI BIOTECNOLOGÍA | 67,92% | 73,56% | 50,44% | 143,64% |
| UBS (LUX) EQUITY SICAV - USA GROWTH (USD) (EUR HEDGED) P-ACC | RVI USA CRECIMIENTO | 18,16% | 66,45% | 50,44% | 254,42% |
| UBS MSCI EM INDEX FUND EUR I-A ACC | RVI EMERGENTES | 51,06% | · | 50,44% | 165,76% |
